Gail Greenwald
Member and Former Director at Launchpad Venture Group
Cambridge, Massachusetts
Gail Greenwald, Member and Former Director at Launchpad Venture Group is an active investor based in Cambridge, Massachusetts. This profile covers what Gail Greenwald backs, at which stage, and how founders can reach out in 2026.
Dr. Gail Greenwald serves as an Angel Investor at Gail Greenwald. She serves as Chair of the Board at Sierra Club Foundation. She served as a Board Observer at WeSpire. She serves as a Board Member at Quantela. She is also an Angel Investor. She served on the Board of Directors at EnergySage. She also served Board Member at Clean Energy Venture Group. Formerly, she was executive vice president of Foliage, which provides consulting and software development services for the medical, aerospace, and industrial equipment markets. She was responsible for corporate-wide P&L management, restructuring and mentoring the current leadership team, and relationship management for major accounts. During her tenure, Foliage achieved sustained profitability through the deep recession and returned to double-digit growth and profitability by mid-2009. She also personally managed the account team for the company's largest client account, with a three-year average annual revenue growth of 67%, solid profitability, and very high client satisfaction. She led Foliage's implementation of new processes for client account planning, client feedback, revenue forecasting, project management and reporting, performance reviews, and internal communications. She holds a B.S. in chemical engineering from MIT and a Ph.D. in chemical engineering from the University of California at Berkeley.
- Investor type
- AngelVCPEInvestor
- Stages
- Early Stage VentureLate Stage Venture
- Invests in
- Climate & EnergySaaS & EnterpriseDigital Health & HealthTechConsumer & Retail
- Location
- Cambridge, Massachusetts
- Typical check
- $3.8M
- Past investments
- 8
Notable investments
WeSpirecognoptixCIMCON Lighting, IncEnergySageNuLabelQuantela Inc.EnergySage, Inc.Arthur D. LittleHow to reach Gail Greenwald
Angels and operators like Gail Greenwald reply to specific, personalized notes that show real traction, not mass blasts. Build a verified list, write a note that fits their thesis, and track replies, all on Round Funded.
Reach active investors like this one
About this profile
This profile is part of Round Funded, an investor database and outreach platform for founders. It covers 60,000+ active VCs, angels, family offices and accelerators with verified contacts, lets you send pitches from your own Gmail, and includes a free Data Room for your raise. How this data is built.
Cite this page
Round Funded. "Gail Greenwald." Round Funded investor database, updated September 9, 2026.
Stable URL, it will not change: https://www.roundfunded.com/en/investor/gail-greenwald
Frequently Asked Questions
What does Gail Greenwald invest in?
Gail Greenwald invests in Climate & Energy, SaaS & Enterprise, Digital Health & HealthTech and Consumer & Retail, typically at Early Stage Venture and Late Stage Venture. Match your sector and stage, then reach out with a personalized pitch.
What stage does Gail Greenwald invest at?
Gail Greenwald typically invests at Early Stage Venture and Late Stage Venture. Lead with traction that fits the stage when you reach out.
What is Gail Greenwald's typical check size?
Gail Greenwald typically writes checks around $3.8M. Use it as a signal for whether your raise fits their stage.
How do founders reach investors like this?
Round Funded lists active investors with verified, professional contact details for signed-up founders. Filter by sector, stage and location, then send a personalized pitch from your own inbox.
What is Round Funded?
Round Funded is an investor database and outreach platform for startup founders. It lists 60,000+ active investors with verified contacts, filtered to recent investment activity, and lets founders send personalized pitches from their own Gmail, track replies, and share a free Data Room. Round+ starts at $99 per month with a 3-day trial.